Brachytherapy
Volume 6, Issue 1 , Pages 38-43 , January 2007

Is seminal vesicle implantation with permanent sources possible? A dose–volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancer

  • Alice Y. Ho

      Affiliations

    • Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY
    • ,
  • Ryan J. Burri

      Affiliations

    • Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY
    • ,
  • Glenn T. Jennings

      Affiliations

    • Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY
    • ,
  • Nelson N. Stone

      Affiliations

    • Department of Urology, Mount Sinai School of Medicine, New York, NY
    • ,
  • Jamie A. Cesaretti

      Affiliations

    • Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY
    • ,
  • Richard G. Stock

      Affiliations

    • Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Mount Sinai Medical Center, Box 1236, One Gustave L. Levy Place, New York, NY 10029-6574. Tel.: +1-212-241-7502; fax: +1-212-410-7194.

Received 12 December 2005 ,Revised 27 September 2006 ,Accepted 28 September 2006.

References 

  1. Terris MK, McNeal JE, Freiha FS, et al. Efficacy of transrectal ultrasound-guided seminal vesicle biopsies in the detection of seminal vesicle invasion by prostate cancer. J Urol. 1993;149:1035–1039
  2. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years. J Urol. 1994;152:1831–1836
  3. Mukamel E, deKernion JB, Hannah J, et al. The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. Cancer. 1987;59:1535–1538
  4. Allepuz Losa CA, Sanz Velez JI, Gil Sanz MJ, et al. Seminal vesicle biopsy in prostate cancer staging. J Urol. 1995;154:1407–1411
  5. Partin AW, Yoo J, Carter HB, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1993;150:110–114
  6. Smith JA, Hernandez AD, Wittwer CJ, et al. Long-term follow-up after radical prostatectomy. Identification of prognostic variables. Urol Clin North Am. 1991;18:473–476
  7. Trapasso JG, deKernion JB, Smith RB, et al. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol. 1994;152:1821–1825
  8. Catalona WJ, Smith DS. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol. 1994;152:1837–1842
  9. Zietman AL, Edelstein RA, Coen JJ, et al. Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcome. Urology. 1994;43:828–833
  10. In:  Beahrs OH,  Hanson DE,  Hutter RVP, et al. editor. Manual for staging of cancer. 4th ed. Philadelphia: Lippincott; 1992;
  11. D'Amico AV, Whittington R, Malkowicz SB, et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol. 1995;154:131–138
  12. Roach M. Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1993;150:1923–1924
  13. Linzer DG, Stock RG, Stone NN, et al. Seminal vesicle biopsy: Accuracy and implications for staging of prostate cancer. Urology. 1996;48:757–761
  14. Vallancien G, Bochereau G, Wetzel O, et al. Influence of preoperative positive seminal vesicle biopsy on the staging of prostatic cancer. J Urol. 1994;152:1152–1156
  15. Stock RG, Cahlon O, Cesaretti JA, et al. Combined modality treatment in the management of high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2004;59:1352–1359
  16. Critz FA, Williams WH, Levinson AK, et al. Simultaneous irradiation for prostate cancer: Intermediate results with modern techniques. J Urol. 2000;164:738–741discussion 741–743
  17. Potters L, Cha C, Ashley R, et al. The role of external beam irradiation in patients undergoing prostate brachytherapy. Urol Oncol. 2000;5:112–117
  18. Singh A, Zelefsky MJ, Raben A, et al. Combined 3-dimensional conformal radiotherapy and transperineal Pd-103 permanent implantation for patients with intermediate and unfavorable risk prostate cancer. Int J Cancer. 2000;90:275–280
  19. Stock RG, Lo YC, Gaildon M, et al. Does prostate brachytherapy treat the seminal vesicles? A dose-volume histogram analysis of seminal vesicles in patients undergoing combined Pd-103 prostate implantation and external beam irradiation. Int J Radiat Oncol Biol Phys. 1999;45:385–389
  20. Stone NN, Stock RG. Laparoscopic pelvic lymph node dissection in the staging of prostate cancer. Mt Sinai J Med. 1999;66:26–30
  21. Stock RG, Stone NN, Wesson MF, et al. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys. 1995;32:219–225
  22. Stock RG, Stone NN, Lo YC. Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant. Tech Urol. 2000;6:95–98
  23. Stone NN, Hong S, Lo YC, et al. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. Brachytherapy. 2003;2:17–25
  24. Jewett HJ, Eggleston JC, Yawn DH. Radical prostatectomy in the management of carcinoma of the prostate: Probable causes of some therapeutic failures. J Urol. 1972;107:1034–1040
  25. Gibbons RP, Cole BS, Richardson RG, et al. Adjuvant radiotherapy following radical prostatectomy: Results and complications. J Urol. 1986;135:65–68
  26. Zeitman AL, Shipley WU, Willet CG. Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications. Cancer. 1993;71(3 Suppl):959–969
  27. Schellhammer PF, el-Mahdi AM, Higgins EM, et al. Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy. J Urol. 1987;137:897–901
  28. Scardino PT, Wheeler TM. Local control of prostate cancer with radiotherapy: Frequency and prognostic significance of positive results of postirradiation prostate biopsy. NCI Monogr. 1988;95–103
  29. Bolla M, van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet. 2005;366:572–578
  30. Swanson GP, Thompson IM, Tangen C, et al. Phase III randomized study of adjuvant radiation therapy versus observation in patients with pathologic T3 prostate cancer (SWOG 8794). Int J Radiat Oncol Biol Phys. 2005;63(Suppl. 1):S1
  31. Ragde H, Elgamal AA, Snow PB, et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer. 1998;83:989–1001
  32. Dattoli M, Wallner K, Sorace R, et al. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys. 1996;35:875–879
  33. Critz FA, Levinson AK, Williams WH, et al. The PSA nadir that indicates potential cure after radiotherapy for prostate cancer. Urology. 1997;49:322–326
  34. Hanks GE, Hanlon AL, Epstein B, et al. Dose response in prostate cancer with 8-12 years' follow-up. Int J Radiat Oncol Biol Phys. 2002;54:427–435
  35. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53:1097–1105
  36. Kestin LL, Goldstein NS, Vicini FA, et al. Treatment of prostate cancer with radiotherapy: Should the entire seminal vesicles be included in the clinical target volume?. Int J Radiat Oncol Biol Phys. 2002;54:686–697
  37. Epstein JI, Partin AW, Potter SR, et al. Adenocarcinoma of the prostate invading the seminal vesicles: Prognostic stratification based on pathologic parameters. Urology. 2000;56:283–288
  38. Zelefsky MJ, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol. 2000;55:241–249

PII: S1538-4721(06)00298-4

doi: 10.1016/j.brachy.2006.09.003

Brachytherapy
Volume 6, Issue 1 , Pages 38-43 , January 2007

Article Tools

* Image Usage & Resolution